Results 91 to 100 of about 36,968 (256)
Biosimilar G-CSF versus filgrastim and lenograstim in healthy unrelated volunteer hematopoietic stem cell donors [PDF]
, 2017 The World Marrow Donor Organization recommends original granulocyte-colony stimulating factor (G-CSF) for the mobilization of stem cells in healthy unrelated hematopoietic stem cell donors. We report the comparison of a biosimilar G-CSF (Zarzio) with two
Bogusz, K +10 more
core +1 more source
Transfusion, EarlyView.Abstract Background Trauma is the most common cause of death in children >1 year of age, with hemorrhage being the most common preventable cause of death after injury. Antifibrinolytics like tranexamic acid (TXA) are a key aspect of trauma management in children, but optimal dosing remains unknown.
Gideon Stitt +5 more
wiley +1 more source
The prevalence of bacterial contamination in donated blood in Dar es salaam, Tanzania [PDF]
, 2012 Blood transfusion services are required to provide blood and components which are safe in cost effective way for transfusion into patients who require the blood products.
Malimu, Emmanuel Zephania
core
Successful treatment of refractory gastrointestinal bleeding by systemic (oral) ankaferd blood stopper in a patient with Glanzmann thrombasthenia [PDF]
, 2015 Background: Glanzmann Thrombasthenia (GT) is a genetic platelet dysfunction and a life threatening disease. Ankaferd Blood Stopper (ABS) is a topical hemostatic agent of herbal origin which has been recently made available for clinical use.
Doğu, Mehmet Hilmi +3 more
core +2 more sources
Transfusion Medicine and Hemotherapy, 2019 Behrouz Mansouri Taleghani +1 more
openaire +2 more sources
Early prediction of transfusion requirements in trauma patients using explainable machine learning
Transfusion, EarlyView.Abstract Introduction Hemorrhagic shock is the most common preventable cause of death in trauma patients. Early transfusion significantly improves survivability in patients suffering from hemorrhagic shock. We hypothesized that machine learning models could reduce time to initial transfusion by more rapidly identifying patients likely to require blood ...
Michael R. De La Rosa +4 more
wiley +1 more source
Frontiers in Public HealthObjectiveThis study aimed to analyze the population characteristics of apheresis platelet donors in Chongqing Province and provide a scientific basis for the development of precise and efficient recruitment strategies.
Ying Cheng +5 more
doaj +1 more source
How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome [PDF]
, 2014 Thrombotic thrombocytopenic purpura (TTP) and atypical haemolytic uraemic syndrome (aHUS) are acute, rare life-threatening thrombotic microangiopathies that require rapid diagnosis and treatment.
Goodship, T, Scully, M
core +1 more source
Declaring futility after traumatic injury and the burden of failure on the surgeon
Transfusion, EarlyView.Abstract In this edition of the THOR supplement in Transfusion, there are two articles that deal with resuscitation futility and transfusion. In one article, Yazer et al. delve into the details of the studies outlined in this editorial and summarize the literature on the topic of transfusion and futility. The second article by Dr.
Jan‐Michael Van Gent, Bryan A. Cotton
wiley +1 more source
Challenges, Difficulties, and Delayed Diagnosis of Multiple Myeloma
DiagnosticsBackground: Multiple myeloma (MM) is a heterogeneous plasma cell malignancy with non-specific symptoms and disease heterogeneity at clinical and biological levels.
Tugba Zorlu +5 more
doaj +1 more source